These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement. Rossi A; Simeoli C; Salerno M; Ferrigno R; Della Casa R; Colao A; Strisciuglio P; Parenti G; Pivonello R; Melis D Orphanet J Rare Dis; 2020 Apr; 15(1):99. PubMed ID: 32306986 [TBL] [Abstract][Full Text] [Related]
5. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. Melis D; Rossi A; Pivonello R; Salerno M; Balivo F; Spadarella S; Muscogiuri G; Casa RD; Formisano P; Andria G; Colao A; Parenti G Orphanet J Rare Dis; 2015 Jul; 10():91. PubMed ID: 26219379 [TBL] [Abstract][Full Text] [Related]
6. Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity. Ernst D; Murphy SM; Sathiyanadan K; Wei Y; Othman A; Laurá M; Liu YT; Penno A; Blake J; Donaghy M; Houlden H; Reilly MM; Hornemann T Neuromolecular Med; 2015 Mar; 17(1):47-57. PubMed ID: 25567748 [TBL] [Abstract][Full Text] [Related]
7. Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus. Mwinyi J; Boström A; Fehrer I; Othman A; Waeber G; Marti-Soler H; Vollenweider P; Marques-Vidal P; Schiöth HB; von Eckardstein A; Hornemann T PLoS One; 2017; 12(5):e0175776. PubMed ID: 28472035 [TBL] [Abstract][Full Text] [Related]
9. Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus. Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T BMJ Open Diabetes Res Care; 2015; 3(1):e000073. PubMed ID: 25815206 [TBL] [Abstract][Full Text] [Related]
10. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry. Kaiser N; Gautschi M; Bosanska L; Meienberg F; Baumgartner MR; Spinas GA; Hochuli M Mol Genet Metab; 2019 Apr; 126(4):355-361. PubMed ID: 30846352 [TBL] [Abstract][Full Text] [Related]
11. Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C. Auranen M; Toppila J; Suriyanarayanan S; Lone MA; Paetau A; Tyynismaa H; Hornemann T; Ylikallio E Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29042446 [TBL] [Abstract][Full Text] [Related]
12. 1-Deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cells. Cordes T; Kuna RS; McGregor GH; Khare SV; Gengatharan J; Muthusamy T; Metallo CM J Lipid Res; 2022 Oct; 63(10):100281. PubMed ID: 36115594 [TBL] [Abstract][Full Text] [Related]
13. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins. Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868 [TBL] [Abstract][Full Text] [Related]
14. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I. Mathis T; Poms M; Köfeler H; Gautschi M; Plecko B; Baumgartner MR; Hochuli M J Inherit Metab Dis; 2022 Mar; 45(2):235-247. PubMed ID: 34671989 [TBL] [Abstract][Full Text] [Related]